Lyse A Norian (Lyse Norian)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 8

Top Venues

Cancers

Cancer research

Cancer

Immunological reviews

University of Alabama at Birmingham

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alabama at Birmingham Aug 05 2015

United States

Associate Professor :: Nutrition Sciences

Publications

Andrew C Brane, Michael Behring, Karina I Halilova, Lyse A Norian
Comments on "Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns". International journal of cancer 149 (6) (2021)
Shannon K Boi, Rachael M Orlandella, Justin Tyler Gibson, William James Turbitt, Gal Wald, Lewis Thomas, Claire Buchta Rosean, Katlyn E Norris, Megan Bing, Laura Bertrand, Brett P Gross, Amani Makkouk, Dmytro Starenki, Kristine I Farag, Robert E Sorge, James A Brown, Jennifer Gordetsky, Hesham Yasin, Rohan Garje, Lakshminarayanan Nandagopal, George J Weiner, David M Lubaroff, Rebecca C Arend, Peng Li, Yousef Zakharia, Eddy Yang, Aliasger K Salem, Kenneth Nepple, Tatiana T Marquez-Lago, Lyse A Norian
Obesity diminishes response to PD-1-based immunotherapies in renal cancer. Journal for immunotherapy of cancer 8 (2) (2021)
William J Turbitt, Shannon K Boi, Justin Tyler Gibson, Rachael M Orlandella, Lyse A Norian
Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice. Cancers 13 (10) (2021)
William J Turbitt, Claire Buchta Rosean, K Scott Weber, Lyse A Norian
Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes. Immunological reviews 295 (1) (2020)
Brandon M Roane, Selene Meza-Perez, Ashwini A Katre, Whitney N Goldsberry, Troy D Randall, Lyse A Norian, Michael J Birrer, Rebecca C Arend
Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma. Molecular cancer therapeutics 20 (3) (2020)
Rachael M Orlandella, Jennifer R Bail, Michael Behring, Karina I Halilova, Roman Johnson, Victoria Williams, Lyse A Norian, Wendy Demark-Wahnefried
Body fat indices and survival in immunotherapy-treated patients with cancer. Cancer 126 (13) (2020)
Rachael M Orlandella, William J Turbitt, Justin Tyler Gibson, Shannon K Boi, Tanja Dudenbostel, Daniel L Smith, Lyse A Norian
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer. Cancers 12 (10) (2020)
Hirokazu Sadahiro, Kyung-Don Kang, Justin T Gibson, Mutsuko Minata, Hai Yu, Junfeng Shi, Rishi Chhipa, Zhihong Chen, Songjian Lu, Yannick Simoni, Takuya Furuta, Hemragul Sabit, Suojun Zhang, Soniya Bastola, Shinobu Yamaguchi, Heba Allah M Alsheikh, Svetlana Komarova, Jun Wang, Sung Hak Kim, Dolores Hambardzumyan, Xinghua Lu, Evan W Newell, Biplab DasGupta, Mitsutoshi Nakada, L James Lee, Louis Burt Nabors, Lyse A Norian, Ichiro Nakano
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma. Cancer research 78 (11) (2018)

Lyse A Norian.css-eqlu8i{font-size:small;padding-left:4px;} (Lyse Norian)

Publication Activity (10 Years)

Top Topics

Top Venues

Lyse A Norian (Lyse Norian)